Clinical trial
Pharmacogenetic Study of Mirtazapine Response in Depressed Patients
NCT01039740 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pharmacogenetic Study of Mirtazapine Response in Depressed Patients
- Lead sponsor
- Samsung Medical Center
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- February 28, 2003
- Completion date
- December 31, 2018
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
depression